PharmEasy buys 66% stake in Thyrocare

Online pharmacy PharmEasys parent will buy a 66.1% stake in diagnostic chain Thyrocare Technologies for 4,546 crore, in a sign that Indians are increasingly using mobile apps for their healthcare needs.
Docon Technologies Pvt. Ltd, a unit of PharmEasys…

Click here to view the original article.